106 related articles for article (PubMed ID: 10211107)
1. The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma.
Pawinski A; Crowther D; Keizer HJ; Voûte PA; Somers R; van Glabbeke M; Lentz MA; van Oosterom AT
Eur J Cancer; 1999 Jan; 35(1):163-4. PubMed ID: 10211107
[No Abstract] [Full Text] [Related]
2. [The application of intraarterial chemotherapy for the treatment of osteogenic sarcoma in children].
Glukhovskaia IIu
Klin Khir; 1997; (2):12-4. PubMed ID: 9424277
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of iproplatin in advanced or metastatic stomach cancer. The EORTC Early Clinical Trial Group.
Sessa C; Cerny T; Kaye S; Monfardini S; Rénard J; Cavalli F
Eur J Cancer; 1990 Jan; 26(1):61-2. PubMed ID: 2138481
[No Abstract] [Full Text] [Related]
4. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
Prindull G; Poppe H; Jentsch E; Schauer A
Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
[No Abstract] [Full Text] [Related]
5. Standard chemotherapy for malignant bony tumors in children and young adults.
Rafique A; Kent PM
Curr Probl Cancer; 2013; 37(4):207-14. PubMed ID: 24238586
[No Abstract] [Full Text] [Related]
6. [Results of surgical and conservative therapy of bone sarcoma in childhood].
Ott G; Hamzei H
Dtsch Med J; 1970 Jan; 21(2):51-5. PubMed ID: 5288560
[No Abstract] [Full Text] [Related]
7. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation.
Kirpensteijn J; Teske E; Kik M; Klenner T; Rutteman GR
Anticancer Res; 2002; 22(5):2765-70. PubMed ID: 12529994
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Osteosarcoma Working Party Group.
Recent Results Cancer Res; 1978; 68():28-32. PubMed ID: 288108
[No Abstract] [Full Text] [Related]
9. [Acid phosphatase indices during irradiation, UHF hyperthermia and chemotherapy of osteogenic sarcoma in children and adolescents].
Bizer VA; D'iakova AM; Boĭko IN; Popova LF
Med Radiol (Mosk); 1986 Nov; 31(11):69-70. PubMed ID: 3465985
[No Abstract] [Full Text] [Related]
10. Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group).
Nitschke R; Pratt C; Harris M; Krischer J; Vietti TJ; Grier H; Kamps W; Toledano S
Invest New Drugs; 1992 Jul; 10(2):93-6. PubMed ID: 1323551
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
12. [Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)].
Krizan Z; Makai F; Krizan I; Blasková L; Látal J; Majeský B
Acta Chir Orthop Traumatol Cech; 1979 Feb; 46(1):26-8. PubMed ID: 88152
[No Abstract] [Full Text] [Related]
13. [Calmodulin in osteogenic sarcoma].
Kushlinskií NE; Trapeznikov NN; Sergeev PV; Solov'ev IN; Shikhammedov MD; Babkina IB; Chukaev SA; Kasumov CM
Biull Eksp Biol Med; 1997 Jun; 123(6):690-2. PubMed ID: 9280529
[No Abstract] [Full Text] [Related]
14. Immunity against tetanus and diphtheria after childhood sarcoma treatment.
Paulides M; Stöhr W; Laws HJ; Graf N; Lakomek M; Berthold F; Schmitt K; Niggli F; Jürgens H; Bielack S; Koscielniak E; Klingebiel T; Langer T
Klin Padiatr; 2010 May; 222(3):196. PubMed ID: 20514629
[No Abstract] [Full Text] [Related]
15. Challenges in the management of bone tumors--1996.
Craft AW
Ann N Y Acad Sci; 1997 Sep; 824():167-79. PubMed ID: 9382441
[No Abstract] [Full Text] [Related]
16. [Osteogenic osteosarcoma and drug therapy. Study in vitro of osteosarcoma's sensitivity to drugs. Therapeutic applications].
Morasca L; Roy-Camille R; Pouliquen JC
Chirurgie; 1970; 96(1):53-62. PubMed ID: 5279883
[No Abstract] [Full Text] [Related]
17. [Current aspects of the treatment of osteogenic sarcoma].
Glukhovskaia IIu; Tolstopiatov BA; Butenko AK; Konovalenko VF
Klin Khir; 1995; (5):32-3. PubMed ID: 8646629
[No Abstract] [Full Text] [Related]
18. Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung.
Cappelaere P; Guiochet N; Bastit P; Favre R; Vanderburg M; Goupil A; Chauvergne J; Thomas D; Van Glabbeke M; Armand JP
Eur J Cancer; 1993; 29A(8):1216. PubMed ID: 8518037
[No Abstract] [Full Text] [Related]
19. Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.
Isakoff MS; Goldsby R; Villaluna D; Krailo MD; Gorlick R; Doski JJ; Womer RB; Janeway KA
Pediatr Blood Cancer; 2016 Feb; 63(2):370-1. PubMed ID: 26376351
[No Abstract] [Full Text] [Related]
20. [Recent aspects of osteosarcoma therapy].
Hoffken K; Schmidt CG
Dtsch Med Wochenschr; 1976 Feb; 101(7):251-8. PubMed ID: 765088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
